Cite
HARVARD Citation
Butelet, A. et al. (2022). Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider. Leukemia & lymphoma. 63 (13), pp. 3100-3104. [Online].